Picture of Zai Lab logo

ZLAB — Zai Lab News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

HK-listed Zai Lab rises on narrower loss in Q3

** Shares of China's biopharmaceutical group Zai Lab Ltd
 9688.HK  jump as much as 10.9% to HK$24.40, their highest since
Aug. 1 
    ** Stock set for biggest one-day pct rise since March 1, if
gains hold; second biggest pct gainer in Hang Seng Composite
Index  .HSCI  
    ** Co posts $69.2 mln net loss for the third quarter of
2023, as compared to a net loss of $161.2 mln a year earlier,
with product revenue up about 22% YoY to $69.2 mln 
    ** Says narrower net loss was due to increase in product
revenue, decline in licensing fees, and shift from foreign
currency loss to gain
    ** Hong Kong's healthcare index  .HSCIH  rises 2.8%
    ** Stock down 2.6% YTD 

 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))

Recent news on Zai Lab

See all news